LEAWOOD, Kan., Sept. 18, 2017 /PRNewswire/ -- Aratana
Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company
focused on the licensing, development and commercialization of
innovative therapeutics for dogs and cats, plans to present at the
Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 10:20 a.m. ET in New
York City.
Interested parties may listen to the webcast live or
access the audio link for up to 90 days after the meeting.
Presentation slides from the conference will also be available in
the Aratana Investor Room.
About Aratana Therapeutics
Aratana Therapeutics is a
pet therapeutics company focused on licensing, developing and
commercializing innovative therapeutics for dogs and cats. Aratana
believes that it can leverage the investment in the human
biopharmaceutical industry to bring therapeutics to pets in a
capital and time efficient manner. The Company's pipeline includes
therapeutic candidates targeting pain, inappetence, cancer, viral
diseases, allergy and other serious medical conditions.
Aratana believes the development and commercialization of these
therapeutics will permit veterinarians and pet owners to manage
pets' medical needs safely and effectively, resulting in longer and
improved quality of life for pets. For more information, please
visit www.aratana.com.
Contacts
For investor inquires:
Craig
Tooman
ctooman@aratana.com
(913) 353-1026
For media inquiries:
Rachel
Reiff
rreiff@aratana.com
(913) 353-1050
View original content with
multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-present-at-cantor-fitzgerald-global-healthcare-conference-300520987.html
SOURCE Aratana Therapeutics, Inc.